Weizhong Wu1, Sanguang Liu2, Yunfei Liang3, Zegao Zhou3, Wei Bian4, Xueqing Liu3. 1. Department of General Surgery, The Second Hospital, Hebei Medical University, Shijiazhuang, China. 2. Department of Hepatobiliary Surgery, The Second Hospital, Hebei Medical University, 215 Heping Road West, Shijiazhuang, 050000, China. junrliu@sina.com. 3. Department of Hepatobiliary Surgery, The Second Hospital, Hebei Medical University, 215 Heping Road West, Shijiazhuang, 050000, China. 4. Department of Hepatobiliary Surgery, The Second Hospital, Hebei Medical University, 215 Heping Road West, Shijiazhuang, 050000, China. weirbian@mailnesia.com.
Abstract
BACKGROUND AND AIMS: The pathogenesis of hepatocellular carcinoma (HC) is unclear. It is suggested that psychological stress associates with the pathogenesis of liver cancer. Bcl2-like protein 12 (Bcl2L12) suppresses p53 protein. This study tests a hypothesis that the major stress hormone, cortisol, inhibits the expression of p53 in HC cells (HCC) via up regulating the expression of Bcl2L12. METHODS: Peripheral blood samples were collected from patients with HC to be analyzed for the levels of cortisol. HCC were cultured to assess the role of cortisol in the regulation of the expression of Bcl2L12 and p53 in HCC. RESULTS: We observed that the serum cortisol levels were higher in HC patients. Expression of Bcl2L12 in HCC was correlated with serum cortisol. Cortisol enhanced the Bcl2L12 expression in HCC. Bcl2L12 binding to the TP53 promoter was correlated with p53 expression in HCC. Cortisol increased the Bcl2L12 expression in HCC to inhibit p53 expression. CONCLUSIONS: Stress hormone cortisol suppresses p53 in HCC via enhancing Bcl2L12 expression in HCC. The results suggest that cortisol may be a therapeutic target for the treatment of HC.
BACKGROUND AND AIMS: The pathogenesis of hepatocellular carcinoma (HC) is unclear. It is suggested that psychological stress associates with the pathogenesis of liver cancer. Bcl2-like protein 12 (Bcl2L12) suppresses p53 protein. This study tests a hypothesis that the major stress hormone, cortisol, inhibits the expression of p53 in HC cells (HCC) via up regulating the expression of Bcl2L12. METHODS: Peripheral blood samples were collected from patients with HC to be analyzed for the levels of cortisol. HCC were cultured to assess the role of cortisol in the regulation of the expression of Bcl2L12 and p53 in HCC. RESULTS: We observed that the serum cortisol levels were higher in HC patients. Expression of Bcl2L12 in HCC was correlated with serum cortisol. Cortisol enhanced the Bcl2L12 expression in HCC. Bcl2L12 binding to the TP53 promoter was correlated with p53 expression in HCC. Cortisol increased the Bcl2L12 expression in HCC to inhibit p53 expression. CONCLUSIONS: Stress hormone cortisol suppresses p53 in HCC via enhancing Bcl2L12 expression in HCC. The results suggest that cortisol may be a therapeutic target for the treatment of HC.
Authors: Alexander H Stegh; Hyunggee Kim; Robert M Bachoo; Kristin L Forloney; Jean Zhang; Harald Schulze; Kevin Park; Gregory J Hannon; Junying Yuan; David N Louis; Ronald A DePinho; Lynda Chin Journal: Genes Dev Date: 2007-01-01 Impact factor: 11.361
Authors: Allyson L Schreiber; Yi-Ling Lu; Brittni B Baynes; Heather N Richardson; Nicholas W Gilpin Journal: Neuropharmacology Date: 2016-05-24 Impact factor: 5.250
Authors: Alexander H Stegh; Cameron Brennan; John A Mahoney; Kristin L Forloney; Harry T Jenq; Janina P Luciano; Alexei Protopopov; Lynda Chin; Ronald A Depinho Journal: Genes Dev Date: 2010-09-13 Impact factor: 11.361